Episode
Embryo base editing milestone & AI-designed universal coronavirus vaccine - News (Jun 6, 2026)
- Podcast
- The Automated Daily
- Published
- Jun 6, 2026
- Duration seconds
- 553
- Processing state
not_requested- Canonical source
- https://theautomateddaily.com/episodes/2026-06-06-embryo-base-editing-milestone-ai-designed-universal-coronavirus-vaccine
Actions
POST https://stenobird.com/v1/public/podcasts/the-automated-daily-6466996/episodes/embryo-base-editing-milestone-ai-designed-universal-coronavirus-vaccine-news-jun-6-2026/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-automated-daily-6466996/embryo-base-editing-milestone-ai-designed-universal-coronavirus-vaccine-news-jun-6-2026.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Please support this podcast by checking out our sponsors: - Discover the Future of AI Audio with ElevenLabs - https://try.elevenlabs.io/tad - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily - KrispCall: Agentic Cloud Telephony - https://try.krispcall.com/tad Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily Today's topics: Embryo base editing milestone - Scientists reported the first use of base editing in early-stage human embryos, a more precise CRISPR-style method, raising fresh safety and ethics concerns around mosaicism and enhancement. AI-designed universal coronavirus vaccine - A Cambridge team says an AI-designed coronavirus “super-antigen” has been tested in humans, aiming for broad protection across coronaviruses and future spillovers—early results were modest but promising. Long-acting HIV prevention rollout - South Africa began rolling out lenacapavir, a twice-yearly PrEP injection that could boost HIV prevention by solving daily-pill adherence issues, but access is constrained by funding cuts and limited supply. New KRAS pancreatic cancer drug - Phase 3 results for daraxonrasib showed markedly longer survival in KRAS-driven metastatic pancreatic cancer, potentially reshaping treatment for a historically hard-to-treat disease if regulators approve it. China’s humanoid robot reality check - China’s humanoid robot makers claim thousands of orders and show off agile machines, but analysts warn real-world usefulness still lags behind production ambitions due to cost, fragility, and messy environments. Canada’s AI sovereignty strategy - Canada unveiled a decade-long AI strategy focused on adoption, AI literacy, and “AI sovereignty,” including plans for domestic compute capac…